Cancer Letters
Volume 286, Issue 2 , Pages 180-188 , 28 December 2009

Chemoradiation interactions under reduced oxygen conditions: Cellular characteristics of an in vitro model

  • An Wouters

      Affiliations

    • Laboratory of Cancer Research and Clinical Oncology, Department of Medical Oncology, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium
    • Corresponding Author InformationCorresponding author. Address: Laboratory of Cancer Research and Clinical Oncology, University of Antwerp, Universiteitsplein 1, Building T3.11, 2610 Wilrijk, Belgium. Tel.: +32 (0)3 265 25 76; fax: +32 (0)3 825 05 64.
    • ,
  • Bea Pauwels

      Affiliations

    • Laboratory of Cancer Research and Clinical Oncology, Department of Medical Oncology, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium
    • ,
  • Hilde A.J. Lambrechts

      Affiliations

    • Laboratory of Cancer Research and Clinical Oncology, Department of Medical Oncology, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium
    • ,
  • Greet G.O. Pattyn

      Affiliations

    • Laboratory of Cancer Research and Clinical Oncology, Department of Medical Oncology, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium
    • ,
  • Johan Ides

      Affiliations

    • Laboratory of Cancer Research and Clinical Oncology, Department of Medical Oncology, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium
    • ,
  • Marc Baay

      Affiliations

    • Laboratory of Cancer Research and Clinical Oncology, Department of Medical Oncology, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium
    • ,
  • Paul Meijnders

      Affiliations

    • Department of Radiotherapy, University Radiotherapy Antwerp (URA), Lindendreef 1, 2020 Antwerp, Belgium
    • ,
  • Sylvia Dewilde

      Affiliations

    • Department of Biomedical Sciences, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium
    • ,
  • Jan B. Vermorken

      Affiliations

    • Laboratory of Cancer Research and Clinical Oncology, Department of Medical Oncology, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium
    • ,
  • Filip Lardon

      Affiliations

    • Laboratory of Cancer Research and Clinical Oncology, Department of Medical Oncology, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium

Received 16 February 2009 ,Revised 19 May 2009 ,Accepted 25 May 2009.

References 

  1. Brown JM. The hypoxic cell: a target for selective cancer therapy – eighteenth Bruce F Cain memorial award lecture. Cancer Res. 1999;59:5863–5870
  2. Vaupel P, Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metast. Rev. 2007;26:225–239
  3. Wouters A, Pauwels B, Lardon F, Vermorken JB. Review: implications of in vitro research on the effect of radiotherapy and chemotherapy under hypoxic conditions. Oncologist. 2007;12:690–712
  4. Gray LH, Conger AD, Ebert M, Hornsey S, Scott OC. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br. J. Radiol. 1953;26:638–648
  5. Horsman MR, Overgaard J. The oxygen effect and tumour microenvironment. In:  Steel GG editors. Basic Clinical Radiobiology. third ed.. New York: Oxford University Press; 2002;p. 158–181
  6. Shannon AM, Bouchier Hayes DJ, Condron CM, Toomey D. Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies. Cancer Treat. Rev. 2003;29:297–307
  7. Russell K, Wiens L, Demers G, Galloway D, Plon S, Groudine M. Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint-competent cells. Cancer Res. 1995;55:1639–1642
  8. Pauwels B, Korst AEC, Andriessen V, Baay MFD, Pattyn GGO, Lambrechts HAJ, et al. Unravelling the mechanism of radiosensitisation by gemcitabine: the role of p53. Radiat. Res. 2005;164:642–650
  9. Pauwels B, Korst AEC, De Pooter CMJ, Pattyn GGO, Lambrechts HAJ, Baay MFD, et al. Comparison of the sulforhodamine B assay and the clonogenic assay for in vitro chemoradiation studies. Cancer Chemother. Pharmacol. 2003;51:221–226
  10. Pauwels B, Korst AEC, Pattyn GGO, Lambrechts HAJ, Van Bockstaele DR, Vermeulen K, et al. Cell cycle effect of gemcitabine and its role in the radiosensitizing mechanism in vitro. Int. J. Radiat. Oncol. Biol. Phys. 2003;57:1075–1083
  11. Franken NA, Rodermond HM, Stap J, Haveman J, Van Bree C. Clonogenic assay of cells in vitro. Nat. Protoc. 2006;1:2315–2319
  12. Fertil B, Dertinger H, Courdi A, Malaise EP. Mean inactivation dose: a useful concept for intercomparison of human cell survival curves. Radiat. Res. 1984;99:73–84
  13. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992;359:843–845
  14. Bristow RG, Hill RP. Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat. Rev. Cancer. 2008;8:180–192
  15. Ziemer LS, Koch CJ, Maity A, Magarelli DP, Horan AM, Evans SM. Hypoxia and VEGF mRNA expression in human tumors. Neoplasia. 2001;3:500–508
  16. Nordsmark M, Hoyer M, Keller J, Nielsen OS, Jensen OM, Overgaard J. The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas. Int. J. Radiat. Oncol. Biol. Phys. 1996;35:701–708
  17. Weinmann M, Marini P, Jendrossek V, Betsch A, Goecke B, Budach W, et al. Influence of hypoxia on trail-induced apoptosis in tumor cells. Int. J. Radiat. Oncol. Biol. Phys. 2004;58:386–396
  18. Hanze J, Eul BG, Savai R, Krick S, Goyal P, Grimminger F, et al. RNA interference for HIF-1alpha inhibits its downstream signalling and affects cellular proliferation. Biochem. Biophys. Res. Commun. 2003;312:571–577
  19. Amellem O, Pettersen E. Cell inactivation and cell cycle inhibition as induced by extreme hypoxia: the possible role of cell cycle arrest as a protection against hypoxia-induced lethal damage. Cell Prolif. 1991;24:127–141
  20. Graeber TG, Peterson JF, Tsai M, Monica K, Fornace AJJ, Giaccia AJ. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol. Cell. Biol. 1994;14:6264–6277
  21. Schmaltz C, Hardenbergh PH, Wells A, Fisher DE. Regulation of proliferation-survival decisions during tumor cell hypoxia. Mol. Cell. Biol. 1998;18:2845–2854
  22. Lee SM, Lee CT, Kim YW, Han SK, Shim YS, Yoo CG. Hypoxia confers protection against apoptosis via PI3K/Akt and ERK pathways in lung cancer cells. Cancer Lett. 2006;242:231–238
  23. Alarcon R, Koumenis C, Geyer RK, Maki CG, Giaccia AJ. Hypoxia induces p53 accumulation through MDM2 down-regulation and inhibition of E6-mediated degradation. Cancer Res. 1999;59:6046–6051
  24. Amellem O, Stokke T, Sandvik JA, Smedshammer L, Pettersen EO. Hypoxia-induced apoptosis in human cells with normal p53 status and function without any alteration in the nuclear protein level. Exp. Cell Res. 1997;232:361–370
  25. Koumenis C, Alarcon R, Hammond E, Sutphin P, Hoffman W, Murphy M, et al. Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. Mol. Cell. Biol. 2001;21:1297–1310
  26. Pan Y, Oprysko P, Asham A, Koch C, Simon M. P53 cannot be induced by hypoxia alone but responds to the hypoxic microenvironment. Oncogene. 2004;23:4975–4983
  27. Samuni AM, Kasid U, Chuang EY, Suy S, DeGraff W, Krishna MC, et al. Effects of hypoxia on radiation-responsive stress-activated protein kinase, p53, and caspase 3 signals in TK6 human lymphoblastold cells. Cancer Res. 2005;65:579–586
  28. Vordermark D, Katzer A, Baier K, Kraft P, Flentje M. Cell type-specific association of hypoxia-inducible factor-1 alpha (HIF-1 alpha) protein accumulation and radiobiologic tumor hypoxia. Int. J. Radiat. Oncol. Biol. Phys. 2004;58:1242–1250
  29. Coleman CN. Hypoxia in tumors: a paradigm for the approach to biochemical and physiologic heterogeneity. J. Natl. Cancer Inst. 1988;80:310–317
  30. Zhang L, Subarsky P, Hill RP. Hypoxia-regulated p53 and its effect on radiosensitivity in cancer cells. Int. J. Radiat. Biol. 2007;83:443–456
  31. Takahashi M, Inanami O, Kubota N, Tsujitani M, Yasui H, Ogura A, et al. Enhancement of cell death by TNF alpha-related apoptosis-inducing ligand (TRAIL) in human lung carcinoma A549 cells exposed to X-rays under hypoxia. J. Radiat. Res. 2007;48:461–468
  32. Moeller BJ, Dewhirst MW. HIF-1 and tumour radiosensitivity. Br. J. Cancer. 2006;95:1–5
  33. Chan N, Koritzinsky M, Zhao H, Bindra R, Glazer PM, Powell S, et al. Chronic hypoxia decreases synthesis of homologous recombination proteins to offset chemoresistance and radioresistance. Cancer Res. 2008;68:605–614
  34. Zolzer F, Streffer C. Increased radiosensitivity with chronic hypoxia in four human tumor cell lines. Int. J. Radiat. Oncol. Biol. Phys. 2002;54:910–920

PII: S0304-3835(09)00379-6

doi: 10.1016/j.canlet.2009.05.026

Cancer Letters
Volume 286, Issue 2 , Pages 180-188 , 28 December 2009

Article Tools

* Image Usage & Resolution